USPH Stock Price | US Physicalrapy Inc P/E, Revenue, EPS, & Forecasts

US Physicalrapy Inc • USPH

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

Calendar

event

Ex dividend date

17 Nov 2025

calendar_clock

Next Dividend Payment

12 Dec 2025

About US Physicalrapy Inc

Ticker

USPH

Trading on

NYSE

ISIN

US90337L1089

Industry

Medical Care Facilities

Sector

Healthcare

CEO

Christopher J. Reading

Headquarters

1300 West Sam Houston Parkway South, Houston, TX, United States, 77042

Employees

4,034

Website

usph.com

U.S. Physical Therapy, Inc. operates and manages outpatient physical therapy clinics. The company operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.

Metrics

BasicAdvanced

Market cap

$1.16B

P/E ratio

32.19

EPS

$2.37

Dividend Yield

2.37%

Beta

1.3

Forward P/E ratio

27.25

EBIDTA

$99.3M

Ex dividend date

2025-11-17

Price & volume

Market cap

$1.16B

Average daily volume

0.2M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$1.79

Dividend yield

2.37%

Forward dividend per share

$1.80

Forward dividend yield

2.39%

Payout ratio

73.17%

Valuation

P/E ratio

32.19

Forward P/E

27.25

PEG ratio

2.72

Trailing P/E

32.19

Price to sales

1.54

Price to book

2.28

Earnings

EPS

$2.37

EPS estimate (current quarter)

$0.66

EPS estimate (next quarter)

$0.69

EBITDA

$99.3M

Revenues (TTM)

$751M

Revenues per share (TTM)

$49.55

Technicals

Beta

1.3

52-week High

$95.83

52-week Low

$61.67

50-day moving average

$82.19

200-day moving average

$78.41

Short ratio

5.43

Short %

6.69%

Management effectiveness

ROE (TTM)

8.44%

ROA (TTM)

4.26%

Profit margin

5.95%

Gross profit margin

$165M

Operating margin

9.95%

Growth

Quarterly earnings growth (YoY)

23.60%

Quarterly revenue growth (YoY)

17.30%

Share stats

Outstanding Shares

15.2M

Float

14.9M

Insiders %

1.94%

Institutions %

107.87%

Analyst Insights & forecasts

86% Buy

14% Hold

0% Sell

Based on information from 7 analysts.

Average price target

$105.33

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

$0.51

$0.70

-26.78%

Q4 • 24Missed

$0.48

$0.45

6.24%

Q1 • 25Beat

$0.81

$0.70

15.71%

Q2 • 25Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$164M

$8.8M

5.37%

Q2 • 25

$164M

$7.2M

4.42%

Q3 • 25

-0.10%

-17.83%

-17.75%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$1.18B

$414M

35.10%

Q2 • 25

$1.2B

$414M

34.59%

Q3 • 25

1.41%

-0.04%

-1.44%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$34.9M

$-12.7M

$-27.3M

$31.6M

Q2 • 25

$19.9M

$-11.9M

$-11M

$15.6M

Q3 • 25

-42.80%

-6.07%

-59.68%

-50.57%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a US Physicalrapy Inc share?

US Physicalrapy Inc shares are currently traded for undefined per share.

How many shares does US Physicalrapy Inc have?

US Physicalrapy Inc currently has 15.2M shares.

Does US Physicalrapy Inc pay dividends?

Yes, US Physicalrapy Inc does pay dividends.

What is US Physicalrapy Inc 52 week high?

US Physicalrapy Inc 52 week high is $95.83.

What is US Physicalrapy Inc 52 week low?

US Physicalrapy Inc 52 week low is $61.67.

What is the 200-day moving average of US Physicalrapy Inc?

US Physicalrapy Inc 200-day moving average is $78.41.

Who is US Physicalrapy Inc CEO?

The CEO of US Physicalrapy Inc is Christopher J. Reading.

How many employees US Physicalrapy Inc has?

US Physicalrapy Inc has 4,034 employees.

What is the market cap of US Physicalrapy Inc?

The market cap of US Physicalrapy Inc is $1.16B.

What is the P/E of US Physicalrapy Inc?

The current P/E of US Physicalrapy Inc is 32.19.

What is the EPS of US Physicalrapy Inc?

The EPS of US Physicalrapy Inc is $2.37.

What is the PEG Ratio of US Physicalrapy Inc?

The PEG Ratio of US Physicalrapy Inc is 2.72.

What do analysts say about US Physicalrapy Inc?

According to the analysts US Physicalrapy Inc is considered a buy.